Universal-Beteiligungs- und Servicegesellschaft’s Jazz Pharmaceuticals JAZZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$32.4M Sell
134,388
-336
-0.2% -$73.6K 0.05% 299
2026
Q1
$25.5M Buy
134,724
+44,635
+50% +$7.8M 0.04% 336
2025
Q4
$15.3M Buy
90,089
+24,991
+38% +$3.83M 0.02% 479
2025
Q3
$8.58M Sell
65,098
-11,473
-15% -$1.38M 0.01% 646
2025
Q2
$8.13M Sell
76,571
-11,225
-13% -$1.22M 0.01% 636
2025
Q1
$10.9M Buy
+87,796
New +$11.5M 0.02% 540

Other funds holding JAZZ

Universal-Beteiligungs- und Servicegesellschaft's JAZZ Position: Q2 2026 in Review

Universal-Beteiligungs- und Servicegesellschaft reduced its Jazz Pharmaceuticals (JAZZ) stake by 0.25% in Q2 2026, selling an estimated $73.6K and leaving 134,388 shares worth $32.4M. The position accounts for 0.05% of the portfolio, ranked #299.

Universal-Beteiligungs- und Servicegesellschaft first reported a position in JAZZ in Q1 2025 and has held it in 6 quarters since. 420 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • Universal-Beteiligungs- und Servicegesellschaft held 134,388 shares of Jazz Pharmaceuticals worth $32.4M as of Q2 2026.
  • Universal-Beteiligungs- und Servicegesellschaft sold 336 Jazz Pharmaceuticals shares in Q2 2026, an estimated $73.6K.
  • Jazz Pharmaceuticals made up 0.05% of Universal-Beteiligungs- und Servicegesellschaft's portfolio in Q2 2026, its #299 holding.
  • Universal-Beteiligungs- und Servicegesellschaft first reported a position in Jazz Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
  • 420 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Universal-Beteiligungs- und Servicegesellschaft's 13F filing for Q2 2026, filed 6 Aug 2026.